Dna Test Articles & Analysis: Older
16 news found
WGS and Dante’s subsequent genomic reports are valuable health tools that can provide physicians and individuals with information about personalised dietary choices, predisposition to genetic diseases, genetic carrier information and more. Traditionally, DNA tests have been limited in the Baltic and Mediterranean regions due to cost and availability of ...
BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of its first oncology liquid biopsy products, Northstar Select™ and Northstar Response™. ...
“The development the Anex® Brush addresses the need for testing high-quality sampling methods. This brush possesses many advantages as it is easy to use without needing for a proctoscope or anoscope. ...
” Highlights from the first quarter and recent weeks include: The American College of Gastroenterology (“ACG”) updated its clinical guideline for the diagnosis and management of esophageal precancer, endorsing, for the first time, nonendoscopic biomarker screening to detect precancer and prevent highly lethal esophageal cancer, providing support for esophageal precancer ...
The updated guideline supports esophageal precancer screening utilizing Lucid’s EsoGuard® DNA Test on samples collected with its EsoCheck® Cell Collection Device, the only such nonendoscopic biomarker screening test available. ...
Pursuant to the agreement, persons covered by MediNcrease clients and payers will have in-network access to Lucid’s EsoGuard® DNA test, the first and only commercially available test capable of serving as a widespread tool to prevent esophageal cancer deaths through the early detection of esophageal precancer in at-risk chronic ...
It involves ribonucleic acid (RNA)-based diagnostics and companion diagnostics development, combining GeneCentric’s extensive pipeline of predictive response gene signatures with Labcorp’s decades-long leadership in bringing new tests to market. RNA-based gene signatures will be co-developed alongside Labcorp Drug Development, while subsequent tests ...
That’s our mission, and we are thrilled to share that our partner, Gateway Genomics, is leveraging our TAP II blood collection technology in its product offering, the SneakPeek Early Gender DNA Test. Called SneakPeek Snap, the blood collection device is included as part of the SneakPeek at-home blood collection kit. ...
The initial project in this expanded collaboration focuses on the co-development of a diagnostic test that identifies women who are most likely to benefit from clinical use of VGX-3100, INOVIO's immunotherapy to treat advanced cervical dysplasia associated with the human papillomavirus (HPV). ...
Each cell’s development, reproduction and death are controlled by the instructions contained in DNA. The History of DNA Sequencing In the 1970s, the first DNA sequences were obtained by academic researching using slow, labor-intense methods. ...
In less than two weeks, World TB Day will be recognized in Puerto Rico and across the globe. March 24th is the official day of recognition and is the same date that back in 1882, Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the cause of tuberculosis (TB). The bacteria can be spread from a person with TB disease of the lungs or throat through the air from one person to ...
“MRSA is known to survive on surfaces for up to 2 weeks,” reported Joe Frasca, Senior Vice President, Marketing at EMSL Analytical, Inc., a leading environmental infectious disease and indoor air quality (IAQ) testing laboratory. “At EMSL, we provide rapid DNA testing for this microbial pathogen. ...
EMSL Analytical, one of the nation’s largest indoor air quality (IAQ) testing laboratories, was one of the first laboratories to offer a mold test kit utilizing technologies developed by the United States Environmental Protection Agency (EPA). ...
HPV testing identifies women with high-risk HPV DNA infections that can cause cervical cancer, enabling diagnosis and treatment to be put in place before cervical cancer develops. ...
In 2009 Merck also announced a partnership with QIAGEN N.V. focused on increasing access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world. This initiative is the first time a vaccine manufacturer and a molecular diagnostics company are collaborating to address the burden of cervical cancer with a comprehensive approach. ...
OptoLabCard project however has created one of only two prototype systems in the world that prepares samples and performs DNA tests on bacteria in a portable, easy-to-use and cost-effective chip. This innovative prototype promises to carry out tests in as little as half an hour. Such an impressive turnaround time combined with low costs would ...